These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 17032651)
21. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. Laederich MB; Funes-Duran M; Yen L; Ingalla E; Wu X; Carraway KL; Sweeney C J Biol Chem; 2004 Nov; 279(45):47050-6. PubMed ID: 15345710 [TBL] [Abstract][Full Text] [Related]
22. Selection of heregulin variants having higher affinity for the ErbB3 receptor by monovalent phage display. Ballinger MD; Jones JT; Lofgren JA; Fairbrother WJ; Akita RW; Sliwkowski MX; Wells JA J Biol Chem; 1998 May; 273(19):11675-84. PubMed ID: 9565588 [TBL] [Abstract][Full Text] [Related]
23. Shh/Ptch and EGF/ErbB cooperatively regulate branching morphogenesis of fetal mouse submandibular glands. Mizukoshi K; Koyama N; Hayashi T; Zheng L; Matsuura S; Kashimata M Dev Biol; 2016 Apr; 412(2):278-87. PubMed ID: 26930157 [TBL] [Abstract][Full Text] [Related]
24. ErbB Receptors and Cancer. Wang Z Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631 [TBL] [Abstract][Full Text] [Related]
25. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain. Elleman TC; Domagala T; McKern NM; Nerrie M; Lönnqvist B; Adams TE; Lewis J; Lovrecz GO; Hoyne PA; Richards KM; Howlett GJ; Rothacker J; Jorissen RN; Lou M; Garrett TP; Burgess AW; Nice EC; Ward CW Biochemistry; 2001 Jul; 40(30):8930-9. PubMed ID: 11467954 [TBL] [Abstract][Full Text] [Related]
26. EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity. Fan YX; Wong L; Johnson GR Biochem J; 2005 Dec; 392(Pt 3):417-23. PubMed ID: 16122376 [TBL] [Abstract][Full Text] [Related]
32. Solution structure of epiregulin and the effect of its C-terminal domain for receptor binding affinity. Sato K; Nakamura T; Mizuguchi M; Miura K; Tada M; Aizawa T; Gomi T; Miyamoto K; Kawano K FEBS Lett; 2003 Oct; 553(3):232-8. PubMed ID: 14572630 [TBL] [Abstract][Full Text] [Related]
33. Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation. Gu J; Chen L; Shatos MA; Rios JD; Gulati A; Hodges RR; Dartt DA Exp Eye Res; 2008 Feb; 86(2):322-34. PubMed ID: 18155194 [TBL] [Abstract][Full Text] [Related]
34. Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry. Ward MD; Leahy DJ J Biol Chem; 2015 Jan; 290(3):1570-9. PubMed ID: 25468910 [TBL] [Abstract][Full Text] [Related]
35. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. Stoll SW; Kansra S; Peshick S; Fry DW; Leopold WR; Wiesen JF; Sibilia M; Zhang T; Werb Z; Derynck R; Wagner EF; Elder JT Neoplasia; 2001; 3(4):339-50. PubMed ID: 11571634 [TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells. Miyazaki Y; Hiraoka S; Tsutsui S; Kitamura S; Shinomura Y; Matsuzawa Y Gastroenterology; 2001 Jan; 120(1):108-16. PubMed ID: 11208719 [TBL] [Abstract][Full Text] [Related]
37. ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells. Gordon-Thomson C; Jones J; Mason RS; Moore GP Melanoma Res; 2005 Feb; 15(1):21-8. PubMed ID: 15714117 [TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells. Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850 [TBL] [Abstract][Full Text] [Related]
39. System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties. Kaushansky A; Gordus A; Budnik BA; Lane WS; Rush J; MacBeath G Chem Biol; 2008 Aug; 15(8):808-17. PubMed ID: 18721752 [TBL] [Abstract][Full Text] [Related]
40. Disabling receptor ensembles with rationally designed interface peptidomimetics. Berezov A; Chen J; Liu Q; Zhang HT; Greene MI; Murali R J Biol Chem; 2002 Aug; 277(31):28330-9. PubMed ID: 12011054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]